abiss CYRENE Instrucciones De Uso página 11

tions with synthetic implants for treating stress urinary incontinence.
• Good surgical practices must be followed when implanting the CYRENE sling. Standardized posto-
perative procedures should be followed.
• Do not let the sling come into contact with potentially damaging instruments (staples, clips or
clamps).
• Check that the sling is placed without tension under the mid-urethra.
• Check the sling is not folded after implantation.
• A cystoscopy must be performed at the end of the procedure to check the integrity of the urethra and
bladder.
• Only use adapted ABISS tunnelling devices.
• The caps in the premium versions are used to clip on the tunnelling devices. They cannot be used for
more than 60 minutes at a time in the human body. In no event should they be implanted. WARNING:
these specifi cations are only applicable for A SINGLE connection or disconnection of the tunneling
device and cap. The safety of any additional use of this equipment cannot be guaranteed.
• This device is a single-use implant. To avoid the transmission of infectious agents, do not re-use.
• After use, this product should be considered as a biological hazard. It should be handled and dis-
posed of in accordance with accepted medical practices and current legal requirements and regula-
tions.
• The management and postoperative monitoring of wounds and infections should be conducted in
accordance with appropriate surgical practices.
• In the event of post-operative infectious complications close to the implantation site, the prosthesis
should be removed in its entirety.
WARNINGS AND RECOMMENDATIONS TO THE PATIENT
As with any surgical procedure, the patient must be warned about certain risk factors:
• Perioperative smoking:
It has been established that perioperative smoking in the adult increases the risk of general complica-
tions (three-fold increase in the risk of infection, two to four-fold increase in the risk of healing complica-
tions). In the event of a prosthetic surgery, the risk of vaginal erosion is markedly increased (multiplied
by four). Smoking should be discontinued six to eight weeks before the procedure to lower the risk of
surgical complications related to tobacco. The continuation of tobacco cessation is recommended for
3 to 4 weeks postoperatively.
• Menopause:
The surgical treatment of urinary incontinence in a menopausal patient could increase the risk of
prosthetic exposure.
• Obesity:
Obesity is a risk factor for infectious type complications in the postoperative period. Weight loss is
advisable before any surgery for urinary incontinence with a prosthesis.
11